Financial Services · Insurance - Property & Casualty · NYSE · United States
$355.11-2.43%
Market cap $140.4BNext earnings 2026-10-20Updated Oct 23, 2026
Our verdict
Trades 12% above our fair value
Price
$355.11
Model fair valueConfidence: good
$317
Model range
$295 to $343
Fair value $317
Price $355
2 models fit Chubb Limited Common Stock and they agree: 2 of 2 land within 15% of the average. The price is above every model.
Two or more of our models back this value.
Premium(i)Silver65
Valued as an insurer: Residual income, P/E comparison, and Dividend discount.
ACCE opinionChubb Limited Common Stock (CB)
Fair value (2 models)
$317
ACCE price target
$382
Rating
Overvalued
Horizon
12 months
Fair value published on 21 Oct 2026, 11:06 CEST; previously $314 since 12 Oct 2026, 00:00 CEST.
ACCE price target published on 24 Oct 2026, 03:20 CEST; previously $372 since 18 Oct 2026, 00:00 CEST.
Rating published on 20 Oct 2026, 14:06 CEST.
Price used: $355 at the close on 23 Oct 2026, 22:00 CEST.
Models: P/E comparison and Residual income.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
12.0% above
-10.7% to fair value
ACCE score
61
out of 100
Analysts
36% buy
25 covering
P/E
12.4x
forward 11.6x
1-year return
+25.5%
Dividend yield
0.27%
Chubb Limited Common Stock in four questions
Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
Overview
ACCE thesis
Chubb writes commercial and personal property and casualty insurance, plus accident and health and specialty lines such as D&O, cyber, and marine, sold through brokers and agents across more than 50 countries. Its moat is underwriting discipline and a global distribution footprint that few peers can match, which shows up in a 23.5% operating margin and a 14.8% ROE. Revenue grew 6.1% in the latest reported period, and with the business compounding through pricing and premium growth in commercial lines, that rate is the one to test against the cycle. At 12.4x trailing earnings and 12.1x forward, the stock is priced below what its margins and returns would normally earn in a broader market. The score of 61/100 and the lack of index membership mean the screen sees a solid but unremarkable profile, so the question for us is whether the underwriting record holds up through a softening pricing cycle.